Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • The cGAS-STING pathway: DNA sensing in health and disease (Jun 2026)
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Impact of bacteria on the phenotype, functions, and therapeutic activities of invariant NKT cells in mice
Sungjune Kim, Saif Lalani, Vrajesh V. Parekh, Tiffaney L. Vincent, Lan Wu, Luc Van Kaer
Sungjune Kim, Saif Lalani, Vrajesh V. Parekh, Tiffaney L. Vincent, Lan Wu, Luc Van Kaer
View: Text | PDF
Research Article Immunology

Impact of bacteria on the phenotype, functions, and therapeutic activities of invariant NKT cells in mice

  • Text
  • PDF
Abstract

Invariant NKT (iNKT) cells are innate-like lymphocytes that recognize glycolipid antigens in the context of the MHC class I–like antigen-presenting molecule CD1d. In vivo activation of mouse iNKT cells with the glycolipid α-galactosylceramide (α-GalCer) results in the acquisition of a hyporesponsive (anergic) phenotype by these cells. Because iNKT cells can become activated in the context of infectious agents, here we evaluated whether iNKT cell activation by microorganisms can influence subsequent responses of these cells to glycolipid antigen stimulation. We found that mouse iNKT cells activated in vivo by multiple bacterial microorganisms, or by bacterial LPS or flagellin, became unresponsive to subsequent activation with α-GalCer. This hyporesponsive phenotype of iNKT cells required IL-12 expression and was associated with changes in the surface phenotype of these cells, reduced severity of concanavalin A–induced hepatitis, and alterations in the therapeutic activities of α-GalCer. These findings may have important implications for the development of iNKT cell–based therapies.

Authors

Sungjune Kim, Saif Lalani, Vrajesh V. Parekh, Tiffaney L. Vincent, Lan Wu, Luc Van Kaer

×

Figure 8

Bacteria-induced iNKT cell hyporesponsiveness is predominantly iNKT cell autonomous.

Options: View larger image (or click on image) Download as PowerPoint
Bacteria-induced iNKT cell hyporesponsiveness is predominantly iNKT cell...
(A) Mice were injected with α-GalCer or heat-killed E. coli and sacrificed at 3 weeks. DCs from the spleen and iNKT cells from the liver were then enriched as described in Methods. iNKT cells (1 × 105 per well) and DCs (5 × 104 per well) were then cultured in different combinations in the presence or absence of α-GalCer. Proliferation was assessed by [3H]thymidine incorporation, and IFN-γ and IL-4 levels in the supernatant were evaluated by ELISA. Data shown are the mean ± SD of 2 wells per group and representative of 2 independent experiments. (B) Mice were injected with α-GalCer or heat-killed E. coli and sacrificed at 3 weeks. DCs and iNKT cells were then MACS purified as described in Methods. DCs (2 × 104 per well) were loaded with α-GalCer and cultured with splenic CFSE-labeled iNKT cells (1 × 105 per well). Cells were harvested 3 days later, stained with anti-B220–PerCP, tetramer-allophycocyanin, and analyzed by flow cytometry. Data shown are CFSE staining on iNKT cells. Three mice per group were pooled for the experiment. (C) Mice were left untreated or injected with heat-killed E. coli or live L. monocytogenes. DCs were MACS purified from naive mice, pulsed with α-GalCer, washed, and then injected i.v. (2 × 105 DCs per mouse) into naive mice or mice treated 3 weeks earlier with the indicated bacteria. As a control, mice were also treated without DCs. Mice were sacrificed 3 days later, and splenocytes were stained with anti–TCR-β–FITC, anti-B220–PerCP, and tetramer-allophycocyanin and analyzed by flow cytometry. Data shown are representative of 2 mice per group.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts